Functional reprogramming of human prostate cancer to promote local attraction of effector CD8+T cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Functional reprogramming of human prostate cancer to promote local attraction of effector CD8+T cells

Published:2016-05-16 Issue:12 Volume:76 Page:1095-1105
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Muthuswamy Ravikumar¹,Corman John M.²,Dahl Kathryn²,Chatta Gurkamal S.³,Kalinski Pawel¹⁴⁵⁶

Affiliation:

1. Department of Surgery; University of Pittsburgh; Pittsburgh Pennsylvania

2. Department of Medicine; Virginia Mason Medical Center; Seattle Washington

3. Department of Urology; Virginia Mason Medical Center; Seattle Washington

4. Infectious Diseases and Microbiology; University of Pittsburgh; Pittsburgh Pennsylvania

5. Department of Immunology; University of Pittsburgh; Pittsburgh Pennsylvania

6. University of Pittsburgh Cancer Institute; University of Pittsburgh; Pittsburgh Pennsylvania

Funder

National Cancer Institute (NCI)

Publisher

Wiley

Subject

Urology,Oncology

Reference65 articles.

1. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

2. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: Updated survival in the TAX 327 study;Berthold;J Clin Oncol,2008

3. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer;Sweeney;N Engl J Med,2015

4. Sipuleucel-T immunotherapy for castration-resistant prostate cancer;Kantoff;N Engl J Med,2010

5. Prostate cancer immunotherapy: Beyond immunity to curability;Simons;Cancer Immunol Res,2014

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of Stimulator of Interferon Genes (STING): Promising Strategy to Overcome Immune Resistance in Prostate Cancer;Current Medicinal Chemistry;2024-12

2. Targeting the tumor microenvironment to improve clinical outcomes in triple negative breast cancer patients and bridge the current disparity gap;Frontiers in Immunology;2024-07-12

3. Havoc in harmony: Unravelling the intricacies of angiogenesis orchestrated by the tumor microenvironment;Cancer Treatment Reviews;2024-06

4. Breaking Barriers: Modulation of Tumor Microenvironment to Enhance Bacillus Calmette–Guérin Immunotherapy of Bladder Cancer;Cells;2024-04-18

5. Mechanisms and measures to modulate T cell trafficking for amplified and tolerogenic immunity;Nano Today;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3